Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
- Products
-
- Atomoxetine Capsules
- Where it was sold
-
Nationwide within the U.S
Nationwide
- Units affected
- 70,032 bottles
- About this recall
- Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-265-30.